The antibody drug conjugates market is estimated to be worth more than 15 billion in 2030

Market-Research

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community

Submitted by Roots_Analysis on 2020-10-09 08:43.

The “Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030

Market-Research

Key Inclusions

An overview of the overall landscape of antibody discovery service providers along with the information on a number of parameters, such as year of establishment, company size, location of headquarters, type of service offered (antigen designing, hit

Submitted by Roots_Analysis on 2020-10-09 08:40.

The antibody discovery services and platforms market is projected to grow at an annualized rate of ~10%

Market-Research

Roots Analysis has done a detailed study on Antibody Discovery: Services and Platforms Market (3rd Edition), 2020-2030, covering key ... Read more

Submitted by Roots_Analysis on 2020-10-09 08:38.

The antibody discovery services market is estimated to be worth around USD 6.5 billion

Market-Research

Antibody therapeutics have made it possible to address the hard to target hotspots, rendering the domain of antibody discovery an emerging sector in the pharmaceutical industry; in fact, the antibodies have proven to be promising weapons in the battle against COVID-19 pandemic. ... Read more

Submitted by Roots_Analysis on 2020-10-09 08:35.

Growing at an annualized rate of over 9%, the antibody discovery services market

Market-Research

High target specificity and favorable safety profiles offered by antibody based pharmacological interventions has created a high demand for such molecules; the domain has witnessed an increased inflow of investments and collaboration opportunities.

Submitted by Roots_Analysis on 2020-10-09 08:33.

The “Targeted Protein Degradation Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapeutics and affiliated technologies, over the next decade.

Pharmaceuticals

To order this 330+ page report, please visit this link

Key Inclusions

A detailed assessment of the current

Submitted by Roots_Analysis on 2020-10-08 08:27.

More than 85 small molecule protein degraders are currently being evaluated for the treatment of various disease indications; in addition, there are over 25 technology platforms available for use in therapy development efforts

Market-Research

The concept of targeted protein degradation presents revolutionary drug development opportunities and is anticipated to bring about a paradigm shift in modern healthcare. The first targeted protein degrader, called proteolysis targeting chimera (PROTAC), was developed about a decade ago. ... Read more

Submitted by Roots_Analysis on 2020-10-08 08:26.

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Market-Research

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ... Read more

Submitted by Roots_Analysis on 2020-10-08 08:25.

Synthetic Lethality-based Drugs and Targets Market, 2019-2030: Focus on DNA Repair (including PARP Inhibitors) and Other Novel Cellular Pathways” report features an extensive study of the current market landscape and the future potential of the synthetic

Pharmaceuticals

To order this detailed 485+ page report, please visit this ... Read more

Submitted by Roots_Analysis on 2020-10-08 08:24.

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment of various types of cancers; presently, there are over 20 screening platforms enabling therapy development efforts

Pharmaceuticals

Advances in screening technologies have enabled the identification of interactive gene combinations, enabling the development of lead candidates that leverage the principle of synthetic lethality for cancer treatment

To order this 485+ page report, which features ... Read more

Submitted by Roots_Analysis on 2020-10-08 08:24.

The synthetic lethality-based drugs and targets market is projected to grow at an annualized rate of ~18%, till 2030

Pharmaceuticals

Roots Analysis has done a detailed study on “ ... Read more

Submitted by Roots_Analysis on 2020-10-08 08:23.

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis

Pharmaceuticals

Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.

Submitted by Roots_Analysis on 2020-10-08 08:21.

The “Targeted Protein Degradation Market, 2020-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape of targeted protein degradation-based therapeutics, providing information on drug / therapy developer(s) (such as year of establishment, company size and location of headquarters), clinical study

Submitted by Roots_Analysis on 2020-10-08 07:49.

More than 85 small molecule protein degraders are currently being evaluated for the treatment

Market-Research

Submitted by Roots_Analysis on 2020-10-08 07:47.

The targeted protein degradation market is projected to grow at an annualized rate of more than 30% till 2030

Market-Research

Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ... Read more

Submitted by Roots_Analysis on 2020-10-08 07:45.

The “Synthetic Lethality-based Drugs and Targets Market, 2019-2030

Market-Research

Key Inclusions

A detailed assessment of the current market landscape, providing information on drug developer(s) (year of establishment, headquarters and size of the company), phase of development (marketed, clinical, preclinical, and discovery stage) of lead

Submitted by Roots_Analysis on 2020-10-08 07:42.

About 75 drug candidates based on synlet gene pairs are being evaluated for the treatment

Market-Research

To order this 485+ page report, which features ... Read more

Submitted by Roots_Analysis on 2020-10-08 07:41.

The synthetic lethality-based drugs and targets market is projected to grow at an annualized

Market-Research

Roots Analysis has done a detailed study on “ ... Read more

Submitted by Roots_Analysis on 2020-10-08 07:38.

The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030

Market-Research

Submitted by Roots_Analysis on 2020-10-08 07:34.

More than 100 subcutaneous biologics have been approved and over 350 such drug candidates are being evaluated in the clinical stages of development, for the treatment of a wide variety of disease indications, claims Roots Analysis

Pharmaceuticals

Several approved therapeutic products, which are currently available as intravenous dosage forms, are being reformulated and evaluated for subcutaneous administration. Further, many existing drug delivery devices, including prefilled syringes, pen injectors, autoinjectors, needle-free ... Read more

Submitted by Roots_Analysis on 2020-10-07 09:21.

Pages